Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Phase II Pilot Study of the Efficacy of FANG(30) to Treat Active Rheumatoid Arthritis in Adult Patients

NCT00749645 is registered in ClinicalTrials.gov with Juan C. Bertoglio, MD as lead sponsor.

NCT NCT00749645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00749645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Phase II Pilot Study of the Efficacy of FANG(30) to Treat Active Rheumatoid Arthritis in Adult Patients
Lead sponsor
Juan C. Bertoglio, MD
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2006
Completion date
February 29, 2008
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid